Efficacy and safety of ranibizumab biosimilars for neovascular age-related macular degeneration: A comprehensive systematic review and meta-analysis
AJO International · 2026-07 · 3 (2) · 100255
DOI: 10.1016/j.ajoint.2026.100255 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift AJO International, 2026-07. Verfasst von Anas Alamoudi und 3 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Alamoudi, A., Alnabihi, A., Almufarriji, N., & AlQahtani, A. S. (2026). Efficacy and safety of ranibizumab biosimilars for neovascular age-related macular degeneration: A comprehensive systematic review and meta-analysis. AJO International, 3(2), 100255. https://doi.org/10.1016/j.ajoint.2026.100255
Vancouver
Alamoudi A, Alnabihi A, Almufarriji N, AlQahtani AS. Efficacy and safety of ranibizumab biosimilars for neovascular age-related macular degeneration: A comprehensive systematic review and meta-analysis. AJO International. 2026;3(2):100255. doi:10.1016/j.ajoint.2026.100255
BibTeX
@article{Alamoudi2026,
author = {Alamoudi, Anas and Alnabihi, Ahmed and Almufarriji, Naif and AlQahtani, Abdullah S},
title = {Efficacy and safety of ranibizumab biosimilars for neovascular age-related macular degeneration: A comprehensive systematic review and meta-analysis},
journal = {AJO International},
year = {2026},
volume = {3},
number = {2},
pages = {100255},
doi = {10.1016/j.ajoint.2026.100255}
}
EUVIMED